Inhibiting its activity can induce angioedema outbreak through insufficient bradykinin degradation (Anderson and deShazo, 1990) as observed in hypertension patients medicated with ACE inhibitors (ACEi-AE). The gene discussed is ACE; the disease is angioedema.